
CPDD LAUNCHES INAUGURAL ADDICTION NEUROBURST PROGRAM AT #CPDD25
The CPDD Program Committee is thrilled to launch Addiction NeuroBurst — a bold new track designed to spotlight addiction neuroscience research. Tailored especially for addiction neuroscience researchers, this track offers dynamic opportunities to grow your network, elevate your research, and connect with leaders shaping the future of the field.
What to Expect:
- Exclusive Small Group Sessions: Engage directly with top scientists in addiction neuroscience in intimate, focused settings designed for meaningful dialogue and mentorship.
- Career-Boosting Connections: Build lasting relationships with established investigators and peers that can open doors to collaborations, funding, and career advancement.
- Premier Poster Presentation Opportunity: Showcase your research in a dedicated early career investigator poster session — purpose-built for visibility and networking with leaders in the field.
Don't miss this chance to plug into the future of addiction neuroscience.
Explore the agenda below and get ready to spark your NeuroBurst!
Schedule
8:00am – 9:00am
Maurepas, Third Floor
Clarity Through Complexity? Promises and Pitfalls of Computational Neuroimaging in Addiction
Presenters: Xiaosi Gu, Ph.D., Jocelyn Ricard, B.S., Anna Konova, Ph.D., Sarah Yip, Ph.D., Chair
9:15am – 10:15am
Maurepas, Third Floor
Pre-Clinical Advances in Understanding the Neurophysiological Consequences of Vaped Drugs of Dependence
Presenters: Michael Taffe, Ph.D., Nathan Olszewski, B.S., Brandon Henderson, Ph.D., Chair, Renata Marchette, Ph.D., Co-Chair
10:45am – 12:15pm
Maurepas, Third Floor
Sex Differences and the Role of Ovarian Hormones in Promoting Nicotine Use and Health Disparities in Females
Presenters: Deniz Bagdas, D.V.M., Ph.D., Brandon Henderson, Ph.D., Ashley White, B.S., Laura O’Dell, Ph.D., Chair
12:30pm – 1:30pm
Grand Ballroom CDE, Fifth Floor
Addiction NeuroBurst Keynote: Eric Nestler, M.D.
Dr. Nestler will share his perspectives on addiction research and offer valuable insights for substance use disorder researchers. This is a valuable opportunity to network with and gain knowledge from one of the leading experts in the field.
1:30pm - 2:30pm
Napoleon Ballroom CD, Third Floor
Poster Viewing and Networking Break
Mentors and mentees will have an opportunity to discuss posters and make valuable connections.
2:30pm - 3:30pm
Maurepas, Third Floor
Astrocytic Contributions to Drug Seeking
Presenters: Anna Kruyer, Ph.D., Leanne Holt, Ph.D., Michael Scofield, Ph.D., Mikhail Pletnikov, M.D., Ph.D., Chair
3:45pm - 4:45pm
Maurepas, Third Floor
NIDA’s “Ten Most Wanted” Targets for Development in Response to the Opioid Crisis – Advances Made Since 2019
Presenters: Robert Dobbins, M.D., Ph.D., Georgette Suidan, Ph.D., Nick Cosford, Ph.D., David White, Ph.D., Chair, Nurulain Zaveri, Ph.D., Co-Chair
5:30pm - 7:00pm
Napoleon Ballroom CD, Third Floor
Poster Session
- “Dose-Extending Placebo Effect” in a Rat Model of Buprenorphine Maintenance Treatment, Emma Pilz, National Institute of Health/NIDA
Mu Opioid Receptor-Expressing Interpeduncular Nucleus Neurons Innervate Brainstem Structures Involved in Mood Regulation and Arousal, Agata Szlaga, University of California San Diego, Department of Neurosciences - Meningeal Plasma Cells and Fen-Specific Iga Antibodies Are Critical to Protection in Fentanyl Vaccine, Mark Harrison, Tulane School of Medicine
Low-Intensity Focused Ultrasound; an Intervention for Fentanyl Addiction, Greatness Olaitan, University of Virginia, Dept of Chemistry
Morphine Amplifies Traumatic Brain Injury Induced Neuroinflammation via the Kynurenine Pathway, Itzick Nahmoud, Wayne State University School of Medicine, Dept of Psychiatry - Associations between Interoceptive Awareness and Resting State Effective Connectivity in Regular Heavy Drinkers and Healthy Controls, Christopher Hammond, Johns Hopkins University School of Medicine
- Impaired Behavioral Flexibility Following Chronic Methamphetamine Use is Attenuated by COX-2 and PGE2 Inhibition in Male and Female rats; Potential Role of PFC Neurons, Amanda Acuna, Arizona State University
- Cue-Induced Neural Activation in Cannabis Use Disorder: A Functional Mri Study, Lisa-Marie Greenwood, Australian National University
- Pairing of the Nicotine Stimulus and Sucrose Reinforcers Must Occur Close in Time to see Interoceptive Conditioning and Later Amplification of Nicotine Taking, Kathleen McNealy, University of Nebraska-Lincoln
- Predicting and Characterizing Substance Use and Psychosis Outcomes in Adolescence Using Neuroimaging, Clinical, and Demographic Factors, Carolyn Amir, University of California, Los Angeles
- Impact of Fentanyl Withdrawal on Neuroinflammation and Blood-Brain Barrier Integrity in Rats, Akhabue Okojie, University of Virginia School of Medicine
- Characterization of Xylazine and Fentanyl and the Reversal, Aniah Matthews, IRP, NIDA, NIH
- From Bench to Bedside: The Development of a Novel Clinical-Stage Therapeutic, KNX100, for the Treatment of Opioid Use Disorder, Rhianne Scicluna, University of Sydney & Kinoxis Therapeutics
- Dysregulations in Sleep Patterns Induced by Fentanyl Self-Administration and Acute Withdrawal Are Altered by Xylazine Co-Use, Christa Corley, University of Kentucky
- Nicotine Use Suppress Cytokine Levels and Dysregulates Neuronal Health in the Ventral Striatum, Daryl Richie, University of Kentucky
- Role of Striatal Acetylcholine in Social and Non-Social Threat Perception, Oyku Dinckol-Perni, Temple University
- Heroin Use Induces a Neurodegenerative-Like Transcriptional Signature in the Dorsal Striatum via Epigenetic Dysregulation of H3K27, Jeremy Sherman, Icahn School of Medicine At Mount Sinai
- Priming with Bupropion Reinstates Drug-Seeking and Enhances Cue-Induced Reinstatement in Male Rats Self-Administering Eutylone or N-Ethylpentylone, MING-HUAN CHAN, National Chengchi University
- Impact of Fentanyl-Xylazine Co-Administration on Sleep, Behavior, and Breathing in Male and Female Mice, Mackenzie Gamble, Boston University School of Medicine
- Cross-Species Analysis of the Role of CACNA1C in the Hippocampus of Subjects following Chronic Alcohol Use: Implications for Context-Induced Relapse, Tanya Pareek, Johns Hopkins University
- Different Stressors Can Either Increase or Decrease Two-Bottle Choice Ethanol Consumption in Male and Female Mice., Ethan Anderson, Louisiana State University
- Inhibition of Ketamine Self-Administration and Reinstatement by Sodium Benzoate in Rats, Hwei-Hsien Chen, National Health Research Institutes
- Parabrachial CGRP Neurons Regulate Opioid Reinforcement and Withdrawal, Lauren Bystrom, Miller School of Medicine, University of Miami
- Fingolimod’s Anxiolytic Effects in Nicotine Withdrawal: Insights from Cell-Specific Mechanisms, Taylor Elder, University of Kentucky
- Sociodemographic Heteroscedasticity in Substance Use Prediction Models: Evidence from the ABCD Study, Christopher Fields, Yale University School of Medicine Department of Psychiatry
- Epigenetic and Transcriptomic Signatures of Morphine-Context Association in the Hippocampus, Rose Sciortino, Department of Neuroscience, Weill Cornell Medicine
- Epigenetic Inheritance Increases Susceptibility to Methamphetamine Taking in Rats, Sarah Swinford-Jackson, Department of Psychological and Brain Sciences, Texas A&M University
Register Now!
Register before April 25 and save!